“Our vision is to provide instruments for accurate diagnosis and monitoring of all patients with ischemia to save limbs, lives, costs and reduce human suffering.”
STOCKHOLM – MARCH 30, 2023 - In cooperation with Perimed AB, researchers from the Department of Biomedical Engineering at Linköping University...
Safety and effectiveness are focus areas for us as a medical device company. By continuously adapting to meet the Quality and Regulatory requirements during...
LAS VEGAS – NOVEMBER 15, 2022 – Perimed Inc has been awarded a group purchasing agreement with Premier Inc effective September 1st, 2022. The...

Disclaimer: It is possible that the products on the Perimed website may not be cleared for sale in all markets.